Celldex Therapeutics Announces Upcoming Investor Presentations and 2016 Year-End Call
February 13 2017 - 2:45PM
Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today upcoming
investor events for February and March.
Upcoming Investor Conferences
Anthony Marucci, Co-founder, President and Chief Executive
Officer, and Thomas Davis, M.D., Executive Vice President and Chief
Medical Officer, will participate in presentations at the following
conferences:
- Leerink Partners 6th Annual Global Healthcare Conference on
Wednesday, February 15, 2017 at 9:30 a.m. EST in New York –
fireside chat
- Cowen and Company 37th Annual Health Care Conference on
Tuesday, March 7, 2017 at 9:20 a.m. EST in Boston – corporate
presentation
Live webcasts of the presentations will be available on the
"Events & Presentations" page of the "Investors & Media"
section of the Celldex website. A replay of the presentations will
be available for seven days following each event.
2016 Year-End Results and Conference
Call/Webcast
- Celldex will release fourth quarter and year-end 2016 financial
results on Tuesday, March 14, 2017 after the U.S. financial markets
close.
- Celldex will host a conference call/webcast at 4:30 p.m. EDT on
the same day to provide an in-depth update on its pipeline and
upcoming milestones for 2017.
Event details, including conference call phone numbers, can be
accessed on the "Events & Presentations" page under the
"Investors & Media" section of the Celldex website.
About Celldex Therapeutics, Inc.Celldex is
developing targeted therapeutics to address devastating diseases
for which available treatments are inadequate. Our pipeline is
built from a proprietary portfolio of antibodies and
immunomodulators used alone and in strategic combinations to create
novel, disease-specific therapies that induce, enhance or suppress
the body's immune response. Visit www.celldex.com.
Contact
Sarah Cavanaugh
Vice President of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com
Charles Liles
Associate Director of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3107
cliles@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2023 to Apr 2024